Colorado MEDtech, CMED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul K who wrote (101)	5/15/1998 2:01:00 PM
From: Edward Larkin	Read Replies (1) of 288

I don't see Vencor buying out CMED, it really doesn't fit into their core operations. As for Vencor wanting to sell the stock, I guess there is some future risk of this, but the facts are that with 34% of the stock they would have to get the deal underwritten. In the past CMED has not taken on any substantial underwriter relationships since they don't need any money and generate cash like mad. The Vencor scenario, even if I think it is unlikely, would cause a underwriter to get involved. With Vencor's stock worth near $35-40 million, it would be enough to get a medium tier bracket firm involved who probably would love to get a bunch of institutions pregnant with this situation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next